Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ADC Antibody
    (2)
  • Antibody-Drug Conjugates (ADCs)
    (1)
  • TNF
    (1)
Filter
Search Result
Results for "

belantamab mafodotin

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
Belantamab mafodotin
GSK2857916, GSK 2857916, Belantamab mafodotin-blm
T779032050232-20-5
Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.
  • Inquiry Price
Size
QTY
Belantamab (FUT-8 KO)
T9901A-824
Belantamab (FUT-8 KO) is a humanized IgG1 monoclonal antibody targeting BCMA (TNFRSF17). It exhibits strong ADCC activity and can be utilized to synthesize the antibody-drug conjugate (ADC), Belantamab mafodotin.
  • Inquiry Price
Size
QTY
Belantamab
GSK2857914
T771292061894-48-0
Belantamab (GSK2857914) is a humanized IgG1 monoclonal antibody against BCMA (TNFRSF17). Belantamab is a naked antibody to Belantamab mafodotin and can be used to synthesize antibody-active molecule conjugates (Belantamab mafodotin).
  • Inquiry Price
Size
QTY